Literature DB >> 17273763

Fibronectin suppression in head and neck cancers, inflammatory tissues and the molecular mechanisms potentially involved.

Ulf Henning Beier1, Claudia Holtmeier, Jan Bernd Weise, Tibor Görögh.   

Abstract

Epithelial cellular fibronectin is frequently repressed after malignant transformation in a variety of cancers. This change has been associated with a loss of contact inhibition. To determine if these findings are unique to malignant processes and to identify mechanisms responsible for fibronectin suppression, we investigated fibronectin expression patterns in 46 head and neck carcinomas, 16 samples of adenoid tissue, and 10 benign mucosal biopsies. We report fibronectin suppression in 78% of the head and neck cancer samples, occurring most prominently within tumor cells, as opposed to the adjacent stroma which exhibited abundant fibronectin. Interestingly, fibronectin was also strongly repressed in chronically inflamed adenoid samples. We showed that fibronectin suppression is mediated by different mechanisms in both benign as well as malignant scenarios: In adenoids, macrophages and T-cells were visualized throughout epithelium that has lost its tight cellular array, allowing leukocyte passage. We have shown that tumor necrosis factor-alpha secreted by macrophages is capable of inducing epithelial derangement via activator protein-1 and nuclear factor-kappaB mediated fibronectin suppression. In head and neck carcinomas, we identified human papilloma virus early protein-2 as a fibronectin transcription inhibitor. We conclude that epithelial fibronectin suppression may not be a hallmark of malignancy, because it can concur with benign processes that involve leukocyte migration. Furthermore, our data suggest that the pattern of fibronectin suppression within the tumor structure largely depends on the cancer cell-stroma relation, which could explain previous conflicting reports on its repression or overexpression along with malignant transformation. In addition, our data support an involvement of human papilloma virus as a mechanism of carcinogenesis mediated via a loss of fibronectin gene expression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17273763

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  5 in total

1.  Monocytes conditioned media stimulate fibronectin expression and spreading of inflammatory breast cancer cells in three-dimensional culture: A mechanism mediated by IL-8 signaling pathway.

Authors:  Mona M Mohamed
Journal:  Cell Commun Signal       Date:  2012-02-10       Impact factor: 5.712

2.  Berberine Suppresses Fibronectin Expression through Inhibition of c-Jun Phosphorylation in Breast Cancer Cells.

Authors:  Yisun Jeong; Daeun You; Hyun-Gu Kang; Jonghan Yu; Seok Won Kim; Seok Jin Nam; Jeong Eon Lee; Sangmin Kim
Journal:  J Breast Cancer       Date:  2018-03-23       Impact factor: 3.588

3.  Growth-arrest-specific 7C protein inhibits tumor metastasis via the N-WASP/FAK/F-actin and hnRNP U/β-TrCP/β-catenin pathways in lung cancer.

Authors:  Ruo-Chia Tseng; Jer-Wei Chang; Jiou-Shan Mao; Charng-Dar Tsai; Pei-Chen Wu; Cuei-Jyuan Lin; Yi-Lin Lu; Sheng-You Liao; Hung-Chi Cheng; Han-Shui Hsu; Yi-Ching Wang
Journal:  Oncotarget       Date:  2015-12-29

4.  Tenascin C, Fibronectin, and Tumor-Stroma Ratio in Pancreatic Ductal Adenocarcinoma.

Authors:  Joni Leppänen; Ville Lindholm; Joel Isohookana; Kirsi-Maria Haapasaari; Peeter Karihtala; Petri P Lehenkari; Juha Saarnio; Joonas H Kauppila; Tuomo J Karttunen; Olli Helminen; Heikki Huhta
Journal:  Pancreas       Date:  2019-01       Impact factor: 3.327

Review 5.  Fibronectin in Cancer: Friend or Foe.

Authors:  Tsung-Cheng Lin; Cheng-Han Yang; Li-Hsin Cheng; Wen-Tsan Chang; Yuh-Rong Lin; Hung-Chi Cheng
Journal:  Cells       Date:  2019-12-20       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.